Reduction of postischemic brain damage and memory deficits following treatment with the selective adenosine A1 receptor agonist

European Journal of Pharmacology

Volumn 302, Issue 1-3, 1996, Pages 43-48

  Von Lubitz, Dag K J E ^a   Beenhakker, Mark ^a   Lin, Rick C S ^b   Carter, Margaret F ^a   Paul, Ian A ^c   Bischofberger, Norbert ^d   Jacobson, Kenneth A ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^d GILEAD SCIENCES   (United States)

Author keywords

(Gerbil); Adenosine receptor; Cerebral ischemia; Spatial memory; Water maze

Indexed keywords

ADENOSINE A1 RECEPTOR AGONIST;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; GERBIL; INTRAPERITONEAL DRUG ADMINISTRATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; STROKE; TREATMENT OUTCOME;

EID: 0030014586     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00101-X     Document Type: Article

References (34)

1. Auer, R.N., M.L. Jensen and I.Q. Winshaw, 1989, Neurobehavioural deficit due to ischemic brain damage limited to half of the CA1 sector of the hippocampus, J. Neurosci. 9, 1641.
2. Bengtsson, F., B.K. Siesjö, 1990, Cell damage in cerebral ischemia: physiological, biochemical, and structural aspects, in: Cerebral Ischemia and Resuscitation, eds. A. Schurr and B.M. Rigor (CRC Press, Boca Raton) p. 215.
3. Bothe, H.-W., H.-J. Bosma, H. Hofer, K.-A. Hossman and W.F. Angermeier, 1986, Selective vulnerability of hippocampus and disturbances of memory storage after mild unilateral ischemia of gerbil brain, Stroke 17, 1160.
4. Choi, D.W., 1992, Excitotoxic cell death, J. Neurobiol. 9, 1261.
5. Corbett, D., S.J. Evans and S.M. Nurse, 1992, Impaired acquisition of the Morris water maze following global ischemic damage in the gerbil, Neuroreport 3, 204.
6. 2 receptor antagonist, reduces cerebral ischemic injury in the Mongolian gerbil, Life Sci. 55, 3.
7. Hagan, J.J. and M. Beughard, 1990, The effects of forebrain ischemia on spatial learning, Behav. Brain Res. 41, 151.
8. 1 agonist on neurochemical, behavioral and histological consequences of ischemia, Brain Res. 641, 217.
9. Jaspers, R.M.A., F. Block, C. Heim and K.-H. Sontag, 1990, Spatial learning is affected by transient occlusion of common carotid arteries (2VO): comparison of behavioural and histopathological changes after '2VO' and 'four-vessel-occlusion' in rats, Neurosci. Lett. 117, 149.
10. Katoh, A., Ch. Ishibashi, T. Shiomi, Y. Takahara and M. Eigyo, 1992, Ischemia-induced irreversible deficit of memory function in gerbils, Brain Res. 577, 57.
11. Knutsen, L.J.S., J. Lau, M.J. Sheardown, K. Eskesen, C. Thomsen, J.U. Weis, M.E. Judge and H. Klitgaard, 1995, Anticonvulsant actions of novel and reference adenosine agonists, in: Adenosine and Adenine Nucleotides: from Molecular Biology to Integrative Physiology, eds. L. Belardinelli and A. Pelleg (Kluwer Academic Publishers, Boston) p. 479.
12. Le Peillet, E., D. Lekieffre, M. Plotkine and R.G. Boulu, 1989, Modified open-field activity test to study the protective activity of drugs in cerebral ischemia in rats (4 vessel model), in: Pharmacology of Cerebral Ischemia 1988, ed. J. Krieglstein (CRC Press, Boca Raton) p. 369.
13. Lee, R.J., J.G. Bajorek, P. Lomax, 1984, Similar anticonvulsive, but unique behavioural effects of opioid agonists in the seizure-sensitive Mongolian gerbil, Neuropharmacology 5, 517.
14. Lin, C.-S., K. Polsky, J.V. Nadler, and B. Crain, 1990, Selective neocortical and thalamic cell death in the gerbil after transient ischemia, Neuroscience 2, 289.
15. 1 selective agonists, J. Pharm. Sci. 1, 46.
16. Mileson, B. and R.D. Schwartz, 1991. The use of locomotor activity as a behavioral screen for neuronal damage following transient forebrain ischemia in gerbils, Neurosci. Lett. 128, 71.
17. Miller, L.P. and C. Hsu, 1992, Therapeutic potential for adenosine receptor activation in ischemic brain injury, J. Neurotrauma 9 (Suppl. 2), S563.
18. Mishkin, M., 1978, Memory in monkeys severely impaired by combined but not by separate removal of amygdala and hippocampus, Nature 273, 297.
19. Mohr, J.P., 1986, Posterior cerebral artery, in: Stroke, eds. H.J.M. Barnett, J.P. Mohr, B.M. Stein and F.M. Yatsu (Churchill Livingstone, New York), 451.
20. Mohr, J.P., J.C. Gautier, D.B. Hier and R.W. Stein, 1986, Middle cerebral artery, in: Stroke, eds. H.J.M. Barnett, J.P. Mohr, B.M. Stein, F.M. Yatsu (Churchill Livingstone, New York) p. 377.
21. Morris, R.G.M., P. Garrud, J.N.P. Rawlins and J. O'Keefe, 1982, Place navigation in rats with hippocampal lesions, Nature 297, 681.
22. O'Keefe, J., L. Nadel, 1978, The Hippocampus as a Cognitive Map (Clarendon, Oxford).
23. Phillis, J.W., M.H. O'Regan, 1988, Deoxycoformycin prevents ischemia-induced locomotor hyperactivity in the unanesthetized gerbil, Med. Sci. Res. 16, 897.
24. Roussel, S., E. Pinard and J. Seylaz, 1991, Focal cerebral ischemia in chronic hypertension: no protection by R-phenylisopropylaenosine, Brain Res. 545, 171.
25. Rudolphi, K.A., P. Schubert, F.E. Parkinson and B.B. Fredholm, 1992, Adenosine and brain ischemia, Cerebrovasc. Brain Metab. Rev. 4, 346.
26. Schubert P. and G.W. Kreutzberg, 1990, Neuroprotective mechanisms of endogenous adenosine action and pharmacological implications, in: Pharmacology of Cerebral Ischemia, ed. J. Krieglstein and H. Oberpichler (Wissenschaftliche Verlagsgesselschaft, Stuttgart) p. 417.
27. Sei, Y., P.K. Arora, P. Skolnick and I.A. Paul, 1992, Spatial learning impairment in a murine model of AIDS, FASEB J. 6, 3008.
28. Von Lubitz, D.K.J.E. and P.J. Marangos, 1990, Cerebral ischemia in gerbils: postischemic administration of cyclohexyladenosine and 8-sulphophenyl-theophylline, J. Mol. Neurosci. 2, 53.
29. Von Lubitz, D.K.J.E. and P.J. Marangos, 1992, Self-defense of the brain: adenosinergic strategies in neurodegeneration, in: Emerging Strategies in Neuroprotection, eds. P.J. Marangos and H. Lal (Birkhauser, Boston) p. 151.
30. Von Lubitz, D.K.J.E., J.M. Dambrosia and D.J. Redmond, 1989, Protective effect of cyclohexyl adenosine in treatment of cerebral ischemia in gerbils, Neuroscience 2, 451.
31. 1 receptor agonist and antagonist on spatial learning and memory, Eur. J. Pharmacol. 249, 271.
32. 1 receptor agonist or antagonist in cerebral ischemia, Eur. J. Pharmacol. 256, 161.
33. Von Lubitz, D.K.J.E., M.F. Carter, M. Beenhakker, R.C.-S. Lin, and K.A. Jacobson, 1996, Adenosine: a prototherapeutic concept in neurodegeneration, in: Neuroprotective Agents, Proceedings of II International Conference, eds. B. Trembly and B. Slikker, Jr., Ann. New York Acad. Sci. 765, 163.
34. Williams, M., 1993, Purinergic drugs: opportunities for the 1990s, Drug Dev. Res. 28, 438.